A government agency has dropped plans to test a controversial treatment for autism that critics had called an unethical experiment on children. The National Institute of Mental Health said in a statement Wednesday that the study of chelation has been discontinued.
The statement says the agency decided the money would be better used testing other potential therapies for autism and related disorders. The study had been on hold because of safety concerns .
A study published last year linked a chemical used in the treatment to lasting brain problems in rats. The treatment removes heavy metals from the body and is based on the fringe theory that mercury in vaccines triggers autism - a theory never proved and rejected by mainstream science.
Methodist Medical Center's new online healthcare program, MyMethodist eHealth, is a proud sponsor of this blog post. MyMethodist eHealth is the secure link to your doctor's office that lets you request appointments, order prescription refills, update your personal health record, and more. Sign up for MyMethodist eHealth here.